Deal Announcements

Forma Therapeutics Lands Second VC Funding

Thursday, December 03, 2009 5:58:00 AM PDT | VentureDeal Staff

Cambridge, Massachusetts  --  Biotechnology company Forma Therapeutics has secured $25.5 million in its series B round of venture capital funding.

Forma says that it is "integrating transformative biology and chemistry to unlock targets and pathways that have been validated through genomic medicine as root causes or major drivers of human cancers."

Strategic investor Lilly Ventures was the lead investor in the round, which also included Novartis Venture Fund and Bio*One Capital.  The company said it would use the funding to focus on its internal target-based oncology programs.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin

PCI - Level1